Prelude Therapeutics Inc (PRLD) stock
PRLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/3055% above fair value
$3.30−0.02 (-0.60%)
Close on Nov 18, 2026Market cap $263.35MP/E –Yield –
Prelude Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Prelude Therapeutics's price to sales ratio was 14.2× on Nov 11, 2026, against 12.2× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 14.2× | −6.8 |
| 2025 | Dec 31, 2025 | 21.0× | – |
See a number that looks wrong?